M W Stewart

Summary

Affiliation: GlaxoSmithKline Research and Development
Country: USA

Publications

  1. ncbi Effect of metformin plus roziglitazone compared with metformin alone on glycaemic control in well-controlled Type 2 diabetes
    M W Stewart
    Solli Klinikk, Jessheim, Norway
    Diabet Med 23:1069-78. 2006
  2. ncbi A double-blind randomized study comparing the effects of continuing or not continuing rosiglitazone + metformin therapy when starting insulin therapy in people with Type 2 diabetes
    P D Home
    School of Medical Sciences Diabetes, The Medical School, Newcastle University, Newcastle upon Tyne, UK
    Diabet Med 24:618-25. 2007
  3. ncbi Effect of insulin therapy on plasma leptin and body weight in patients with type 2 diabetes
    P E Carey
    Diabetes Centre, Newcastle upon Tyne
    Horm Metab Res 35:372-6. 2003

Collaborators

Detail Information

Publications3

  1. ncbi Effect of metformin plus roziglitazone compared with metformin alone on glycaemic control in well-controlled Type 2 diabetes
    M W Stewart
    Solli Klinikk, Jessheim, Norway
    Diabet Med 23:1069-78. 2006
    ..To investigate the effect of metformin plus roziglitazione (RSGMET) compared with metformin alone (MET) on glycaemic control in well-controlled Type 2 diabetes...
  2. ncbi A double-blind randomized study comparing the effects of continuing or not continuing rosiglitazone + metformin therapy when starting insulin therapy in people with Type 2 diabetes
    P D Home
    School of Medical Sciences Diabetes, The Medical School, Newcastle University, Newcastle upon Tyne, UK
    Diabet Med 24:618-25. 2007
    ..To compare the efficacy and safety of either continuing or discontinuing rosiglitazone + metformin fixed-dose combination when starting insulin therapy in people with Type 2 diabetes inadequately controlled on oral therapy...
  3. ncbi Effect of insulin therapy on plasma leptin and body weight in patients with type 2 diabetes
    P E Carey
    Diabetes Centre, Newcastle upon Tyne
    Horm Metab Res 35:372-6. 2003
    ..This study set out to define relationships between changes in plasma leptin and changes in body weight, plasma insulin and blood glucose control during a 12-month crossover study of once-daily Ultratard or twice-daily Insulatard insulin...